← back to search

N.R. Silvaggi

University of Wisconsin–Milwaukee · US

Area of research

Neurology · Materials Chemistry

Research interest

Research interests include Enzyme Structure and Function, Botulinum Toxin and Related Neurological Disorders, Biochemical and Molecular Research, and Peptidase Inhibition and Analysis.

h-index

22

citations

1,575

works

90

NIH funding

—

primary concept

—

email

✉ Find email ↗

Recent publications

Oral and Inhaled Fosamprenavir Reverses Pepsin‐Induced Damage in a Laryngopharyngeal Reflux Mouse Model

The Laryngoscope 2022cited by 18position: middledoi

Evaluation of adamantane hydroxamates as botulinum neurotoxin inhibitors: Synthesis, crystallography, modeling, kinetic and cellular based studies

Bioorganic & Medicinal Chemistry 2012cited by 47position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

— · 1 papers (2012–2012)Nikki Johnston · Medical College of Wisconsin1 papers (2022–2022)Kim D. Janda · Scripps Institution of Oceanography1 papers (2012–2012)— · 1 papers (2012–2012)Nemanja Vuksanovic · Boston University1 papers (2022–2022)Leggy A. Arnold · New York Medical College1 papers (2022–2022)— · 1 papers (2022–2022)Alexander C. Mackinnon · University of Alabama at Birmingham1 papers (2022–2022)Karen N. Allen · Boston University1 papers (2012–2012)Frank G. Ondrey · Rush University Medical Center1 papers (2022–2022)Eric A. Johnson · University of Massachusetts Amherst1 papers (2012–2012)Tina L. Samuels · Medical College of Wisconsin1 papers (2022–2022)Brian C. Smith · Princeton University1 papers (2022–2022)James A. Miller · Roswell Park Comprehensive Cancer Center1 papers (2022–2022)— · 1 papers (2012–2012)Joel H. Blumin · Medical College of Wisconsin1 papers (2022–2022)Timothy S. Wiedmann · NewYork–Presbyterian Hospital1 papers (2022–2022)Beverly R. Wuertz · University of Minnesota, Twin Cities1 papers (2022–2022)Jonathan M. Bock · Medical College of Wisconsin1 papers (2022–2022)